Cargando…

Therapy of Mucormycosis

Despite the recent introduction of mold-active agents (posaconazole and isavuconazole), in addition to amphotericin B products, to our armamentarium against mucormycosis, many uncertainties remain for the management of this uncommon opportunistic infection, as there are no data from prospective rand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sipsas, Nikolaos V., Gamaletsou, Maria N., Anastasopoulou, Amalia, Kontoyiannis, Dimitrios P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162664/ https://www.ncbi.nlm.nih.gov/pubmed/30065232 http://dx.doi.org/10.3390/jof4030090

Ejemplares similares

Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies
por: Gamaletsou, Maria N., et al.
Publicado: (2018)

Is Sjögren's syndrome a retroviral disease?
por: Sipsas, Nikolaos V, et al.
Publicado: (2011)

Mucormycosis of the Central Nervous System
por: Chikley, Amanda, et al.
Publicado: (2019)

When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
por: John, Teny M., et al.
Publicado: (2021)

Mucormycosis in 2023: an update on pathogenesis and management
por: Alqarihi, Abdullah, et al.
Publicado: (2023)

A Potential Explanation of a Positive Serum β-Glucan Assay in Mucormycosis
por: Kontoyiannis, Dimitrios P.
Publicado: (2016)

Osteoarticular Infections Caused by Non-Aspergillus Filamentous Fungi in Adult and Pediatric Patients: A Systematic Review
por: Taj-Aldeen, Saad J., et al.
Publicado: (2015)

Necrotizing Mucormycosis of Wounds Following Combat Injuries, Natural Disasters, Burns, and Other Trauma
por: Walsh, Thomas J., et al.
Publicado: (2019)

Candida Arthritis: Analysis of 112 Pediatric and Adult Cases
por: Gamaletsou, Maria N., et al.
Publicado: (2015)

Are Unique Regional Factors the Missing Link in India’s COVID-19-Associated Mucormycosis Crisis?
por: Skaria, Jessy, et al.
Publicado: (2022)

Association between COVID-19 vaccination status, time elapsed since the last vaccine dose, morbidity, and absenteeism among healthcare personnel: A prospective, multicenter study
por: Maltezou, Helena C., et al.
Publicado: (2022)

Impaired distensibility of ascending aorta in patients with HIV infection
por: Zormpala, Alexandra, et al.
Publicado: (2012)

Diet Modification and Metformin Have a Beneficial Effect in a Fly Model of Obesity and Mucormycosis
por: Shirazi, Fazal, et al.
Publicado: (2014)

Effectiveness of a Self-Decontaminating Coating Containing Usnic Acid in Reducing Environmental Microbial Load in Tertiary-Care Hospitals
por: Maltezou, Helena C., et al.
Publicado: (2023)

COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study
por: Maltezou, Helena C., et al.
Publicado: (2021)

Breath-Based Diagnosis of Invasive Mucormycosis (IM)
por: Koshy, Seena, et al.
Publicado: (2017)

Impact of Hyperglycemia and Diabetes Mellitus on Breakthrough Mucormycosis Outcomes in Patients with Hematologic Malignancies—Complex and Intriguing Associations
por: Franklin, Alexander, et al.
Publicado: (2022)

Leishmaniasis, Autoimmune Rheumatic Disease, and Anti–Tumor Necrosis Factor Therapy, Europe
por: Xynos, Ioannis D., et al.
Publicado: (2009)

Taking a Closer Look: Clinical and Histopathological Characteristics of Culture-Positive versus Culture-Negative Pulmonary Mucormycosis
por: Spallone, Amy, et al.
Publicado: (2022)

710. Comparison of Initial CXR to CT in Patients (pts) with Hematologic Malignancy (HEM) and Documented Symptomatic Pulmonary Mucormycosis (PM)
por: Franklin, Alexander, et al.
Publicado: (2021)

18-Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scan for monitoring the therapeutic response in experimental Staphylococcus aureus foreign-body osteomyelitis
por: Chatziioannou, Sofia, et al.
Publicado: (2015)

Early 3‑day course of remdesivir for the prevention of the progression to severe COVID‑19 in the elderly: A single‑centre, real‑life cohort study
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

Bone Marrow Iron Stores Are Not Associated with Increased Risk for Invasive Fungal Infections in Patients with Newly Diagnosed Acute Leukemia or Myelodysplastic Syndrome in Transformation: Is There a Relationship?
por: Apostolidi, Eirini A., et al.
Publicado: (2023)

848. Discordant Chest Radiography and Computed Tomography Findings in Patients with Hematologic Malignancy and Invasive Mucormycosis: What Are the Prognostic Implications?
por: Wurster, Sebastian, et al.
Publicado: (2023)

Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations
por: Anastasopoulou, Amalia, et al.
Publicado: (2019)

Beyond Immunotherapy: Seizing the Momentum of Oncolytic Viruses in the Ideal Platform of Skin Cancers
por: Ziogas, Dimitrios C., et al.
Publicado: (2022)

Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study
por: Kontoyiannis, Dimitrios P., et al.
Publicado: (2016)

COVID-19 and Respiratory Virus Co-Infections: A Systematic Review of the Literature
por: Maltezou, Helena C., et al.
Publicado: (2023)

Protection of vaccination versus hybrid immunity against infection with COVID-19 Omicron variants among Health-Care Workers
por: Ntziora, Fotinie, et al.
Publicado: (2022)

Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer
por: Axell-House, Dierdre B., et al.
Publicado: (2021)

Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study
por: Basoulis, Dimitrios, et al.
Publicado: (2023)

Immature granulocytes: Innovative biomarker for SARS-CoV-2 infection
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2022)

Factors predicting poor outcomes of patients treated with tocilizumab for COVID‑19‑associated pneumonia: A retrospective study
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2022)

Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy
por: Ziogas, Dimitrios C, et al.
Publicado: (2020)

Effectiveness of full (booster) COVID-19 vaccination against severe outcomes and work absenteeism in hospitalized patients with COVID-19 during the Delta and Omicron waves in Greece
por: Maltezou, Helena C., et al.
Publicado: (2023)

255. Breakthrough Mucormycosis (BT-MCR) on Antifungals Having Mucorales Activity Portrays Worse Prognosis compared with BT-MCR on Mold-Active Antifungals with no Mucorales Activity
por: Axell-House, Dierdre B, et al.
Publicado: (2019)

Disseminated Mucormycosis with Positive Aspergillus Galactomannan
por: Kitmiridou, Despoina, et al.
Publicado: (2018)

When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report
por: Ziogas, Dimitrios C, et al.
Publicado: (2020)

Epidemiology and Diagnosis of Mucormycosis: An Update
por: Skiada, Anna, et al.
Publicado: (2020)

Isavuconazole as salvage therapy for mucormycosis
por: Graves, Bianca, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f53cguu3vgefdhh3qj9i5cdori